CoChat
Sign Up
Cited by 14Botulinum Toxin and Related Neurological DisordersStroke Rehabilitation and RecoveryPatient-Provider Communication in Healthcare

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Enhancing patient-provider communication for long-term post-stroke spasticity management

Sunnerhagen, K. S., Francisco, G. E.·2013·Acta Neurologica Scandinavica
DOI 10.1111/ane.12128
Open this paper in CoChat — free account

Abstract

Stroke is a major public health concern, with estimated 16 million people worldwide experiencing first-time strokes each year, a number that is expected to rise. Two-thirds of those experiencing a stroke are younger than 70 years of age. Stroke is a leading cause of disability in adults as a result of major sequelae that include spasticity, cognitive impairment, paresis, and depression. Disabling spasticity, defined as spasticity severe enough to require intervention, occurs in 4% of stroke survivors within 1 year of first-time stroke. The aim of this report is to focus instead on a discussion of patient-provider communication, and its role in post-stroke spasticity (PSS) rehabilitation within the context of patient-centered health care. A discussion based on a review of the literature, mainly since 2000. Problems within communication are identified and suggestion to enhance communication are proposed thus improving patient-centered goal setting/goal achievement for the effective management of spasticity rehabilitation. These are as follows: (i) involving family members, (ii) educating patients and family members on stroke and rehabilitation, and (iii) establishing a common definition for long-term goals. Increased communication among physicians, patients, and payers may bridge some of the gaps and increase the effectiveness of PSS rehabilitation and management.

Overview

Integrity signals

Registry

Crossref · 10.1111/ane.12128

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. Strong, 2007, Preventing stroke: saving lives around the world, Lancet Neurol, 6, 182, 10.1016/S1474-4422(07)70031-5 · DOI
  2. Wolfe, 2000, The impact of stroke, Br Med Bull, 56, 275, 10.1258/0007142001903120 · DOI
  3. Lloyd-Jones, 2010, Heart disease and stroke statistics-2010 update: a report from the American Heart Association, Circulation, 121, e46, 10.1161/CIRCULATIONAHA.109.192667 · DOI · Paper page
  4. Peltonen, 2000, Social patterning of myocardial infarction and stroke in Sweden: incidence and survival, Am J Epidemiol, 151, 283, 10.1093/oxfordjournals.aje.a010204 · DOI
  5. Gormley, 1997, A clinical overview of treatment decisions in the management of spasticity, Muscle Nerve Suppl, 6, S14, 10.1002/(SICI)1097-4598(1997)6+<14::AID-MUS3>3.0.CO;2-M · DOI
  6. Treger, 2007, Return to work in stroke patients, Disabil Rehabil, 29, 1397, 10.1080/09638280701314923 · DOI
  7. Palmcrantz, 2012, Long-term health states relevant to young persons with stroke living in the community in southern Stockholm - a study of self-rated disability and predicting factors, Disabil Rehabil, 34, 817, 10.3109/09638288.2011.621507 · DOI
  8. Hofgren, 2007, Recovery after stroke: cognition, ADL function and return to work, Acta Neurol Scand, 115, 73, 10.1111/j.1600-0404.2006.00768.x · DOI
  9. Malm, 1999, Clinical features and prognosis in young adults with infratentorial infarcts, Cerebrovasc Dis, 9, 282, 10.1159/000015979 · DOI
  10. Urban, 2010, Occurence and clinical predictors of spasticity after ischemic stroke, Stroke, 41, 2016, 10.1161/STROKEAHA.110.581991 · DOI
  11. Welmer, 2006, Spasticity and its association with functioning and health-related quality of life 18 months after stroke, Cerebrovasc Dis, 21, 247, 10.1159/000091222 · DOI
  12. Lance, 1980, The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture, Neurology, 30, 1303, 10.1212/WNL.30.12.1303 · DOI
  13. Young, 1994, Spasticity: a review, Neurology, 44, S12
  14. Marciniak, 2011, Poststroke hypertonicity: upper limb assessment and treatment, Top Stroke Rehabil, 18, 179, 10.1310/tsr1803-179 · DOI
  15. Sommerfeld, 2004, Spasticity after stroke: its occurrence and association with motor impairments and activity limitations, Stroke, 35, 134, 10.1161/01.STR.0000105386.05173.5E · DOI
  16. Watkins, 2002, Prevalence of spasticity post stroke, Clin Rehabil, 16, 515, 10.1191/0269215502cr512oa · DOI
  17. Bhattacharya, 2005, A 5 years prospective study of incidence, morbidity and mortality profile of stroke in a rural community of eastern India, J Indian Med Assoc, 103, 655
  18. Lundstrom, 2008, Prevalence of disa bling spasticity 1 year after first-ever stroke, Eur J Neurol, 15, 533, 10.1111/j.1468-1331.2008.02114.x · DOI
  19. Wissel, 2009, European consensus table on the use of botulinum toxin type A in adult spasticity, J Rehabil Med, 41, 13, 10.2340/16501977-0303 · DOI
  20. Brashear, 2009, Spasticity, Curr Treat Options Neurol, 11, 153, 10.1007/s11940-009-0018-4 · DOI
  21. Gracies, 1997, Traditional pharmacological treatments for spasticity. Part II: General and regional treatments, Muscle Nerve Suppl, 6, S92, 10.1002/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E · DOI
  22. Cameron, 2008, Optimizing stroke systems of care by enhancing transitions across care environments, Stroke, 39, 2637, 10.1161/STROKEAHA.107.501064 · DOI
  23. WHO, 2005, Preparing a health care workforce for the 21st Century:the challenge of chronic conditions
  24. Leach, 2010, Patient centered goal-setting in a subacute rehabilitation setting, Disabil Rehabil, 32, 159, 10.3109/09638280903036605 · DOI
  25. Batcho, 2012, ACTIVLIM-Stroke: a crosscultural Rasch-built scale of activity limitations in patients with stroke, Stroke, 43, 815, 10.1161/STROKEAHA.111.638965 · DOI
  26. Bhakta, 2000, Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial, J Neurol Neurosurg Psychiatry, 69, 217, 10.1136/jnnp.69.2.217 · DOI
  27. Kelley, 2009, Stroke rehabilitation, Neurol Res, 31, 832, 10.1179/016164109X12445505689689 · DOI
  28. WHO, 2001, International classification of functioning, disability and health: ICF, 299
  29. Ghatnekar, 2004, Cost of stroke in Sweden: an incidence estimate, Int J Technol Assess Health Care, 20, 375, 10.1017/S0266462304001217 · DOI
  30. Persson, 2012, Economic burden of stroke in a large county in Sweden, BMC Health Serv Res, 12, 341, 10.1186/1472-6963-12-341 · DOI
  31. Lundstrom, 2010, Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event, Stroke, 41, 319, 10.1161/STROKEAHA.109.558619 · DOI
  32. Turner-Stokes, 2009, Goal attainment scaling (GAS) in rehabilitation: a practical guide, Clin Rehabil, 23, 362, 10.1177/0269215508101742 · DOI
  33. Evans, 1994, Stroke: a family dilemma, Disabil Rehabil, 16, 110, 10.3109/09638289409166287 · DOI
  34. Tellier, 2011, Impact of mild stroke on the quality of life of spouses, Int J Rehabil Res, 34, 209, 10.1097/MRR.0b013e328343d540 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sunnerhagen, K. S., & Francisco, G. E.
Affiliations
  • University of Gothenburg (SE)
  • Memorial Hermann Institute for Rehabilitation and Research Foundation (US)
Corresponding author
Sunnerhagen, K. S.
ORCID
Venue
Acta Neurologica Scandinavica
Publisher
Hindawi Limited
Published
2013-04
Volume
128
Issue
5
Pages
n/a-n/a
ISSN
0001-6314 (ISSN-L)
DOI
10.1111/ane.12128
OpenAlex
W1965894137
Cited by
14
References
1
Citations by year
2025: 2 · 2024: 2 · 2023: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2
FWCI
0.13
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 883 d)
Locations
  • Acta Neurologica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • World Health Organization
  • Stroke Association
  • Allergan
Topics
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Keywords
post-stroke spasticity, patient-provider communication, patient-centered care, goal setting, family involvement, patient and family education, stroke sequelae
MeSH terms
Humans, Muscle Spasticity, Caregivers, Disease Management, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review